A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment

Details for Australian Patent Application No. 2010224510 (hide)

Owner Sanofi

Inventors Clot, Pierre-Francois; Dubruc, Catherine

Agent A J Park

Pub. Number AU-A-2010224510

PCT Pub. Number WO2010/106519

Priority 09290202.2 19.03.09 EP

Filing date 18 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 31/727 (2006.01)

A61K 31/765 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/106519 Priority application(s): WO2010/106519

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224515-Toothbrush

2010224502-Optical signature to enable image correction